Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcela A Ferrada

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Arthritis Care & Research|February 5, 2021
Physician Global Assessment as a Disease Activity Measure for Relapsing PolychondritisEmily Rose, Marcela A Ferrada, Kaitlin A Quinn, et al.
American Journal of Clinical Pathology|May 26, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndromePaul A Wadsworth, Simon B Chen, Lauren Lawrence, et al.
Blood Advances|July 21, 2023
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndromeYanna Ding, Alina E Dulau-Florea, Emma M Groarke, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Ultra-Rare Genetic Variation in Relapsing Polychondritis: A Whole-Exome Sequencing StudyYiming Luo, Marcela A Ferrada, Keith A Sikora, et al.
Annals of the Rheumatic Diseases|November 2, 2023
Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing studyYiming Luo, Marcela A Ferrada, Keith A Sikora, et al.
Seminars in Arthritis and Rheumatism|January 1, 2022
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndromeYiming Luo, Ertugrul Cargi Bolek, Kaitlin A Quinn, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Arthritis Care & Research|February 5, 2021
Physician Global Assessment as a Disease Activity Measure for Relapsing PolychondritisEmily Rose, Marcela A Ferrada, Kaitlin A Quinn, et al.
American Journal of Clinical Pathology|May 26, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndromePaul A Wadsworth, Simon B Chen, Lauren Lawrence, et al.
Blood Advances|July 21, 2023
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndromeYanna Ding, Alina E Dulau-Florea, Emma M Groarke, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Ultra-Rare Genetic Variation in Relapsing Polychondritis: A Whole-Exome Sequencing StudyYiming Luo, Marcela A Ferrada, Keith A Sikora, et al.
Annals of the Rheumatic Diseases|November 2, 2023
Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing studyYiming Luo, Marcela A Ferrada, Keith A Sikora, et al.
Seminars in Arthritis and Rheumatism|January 1, 2022
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndromeYiming Luo, Ertugrul Cargi Bolek, Kaitlin A Quinn, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
JAMA Dermatology|June 12, 2024
Skin Manifestations of VEXAS Syndrome and Associated GenotypesIsabella J Tan, Marcela A Ferrada, Serene Ahmad, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
Pageof 4